Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes
Abstract
Suppressive acyclovir therapy reduced the need for cesarean for recurrent herpes in women whose first clinical episode of genital HSV occurred during pregnancy. Suppressive acyclovir treatment did not increase asymptomatic viral shedding and was not harmful to the term fetus.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
pregnancy
research support
non-u.s. gov't
adult
female
Infant
Prospective Studies
newborn
pregnancy outcome
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
pregnancy complications
antiviral agents / therapeutic use*
acyclovir / therapeutic use*
infectious / drug therapy*
herpes genitalis / drug therapy*
cesarean section / statistics & numerical data
pmid:8532270
doi:10.1016/0029-7844(95)00357-6
l l scott
p j sanchez
g d wendel
Access
Citation
ID:
115800
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
115800
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet